These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 18349850)
1. Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53. Szybka M; Zawlik I; Kulczycka D; Golanska E; Jesien E; Kupnicka D; Stawski R; Piaskowski S; Bieniek E; Zakrzewska M; Kordek R; Liberski PP; Rieske P Br J Cancer; 2008 Apr; 98(8):1431-3. PubMed ID: 18349850 [TBL] [Abstract][Full Text] [Related]
2. p53 mutation and epidermal growth factor receptor overexpression in glioblastoma. Yoon KS; Lee MC; Kang SS; Kim JH; Jung S; Kim YJ; Lee JH; Ahn KY; Lee JS; Cheon JY J Korean Med Sci; 2001 Aug; 16(4):481-8. PubMed ID: 11511795 [TBL] [Abstract][Full Text] [Related]
3. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Newcomb EW; Madonia WJ; Pisharody S; Lang FF; Koslow M; Miller DC Brain Pathol; 1993 Jul; 3(3):229-35. PubMed ID: 8293182 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Watanabe K; Tachibana O; Sata K; Yonekawa Y; Kleihues P; Ohgaki H Brain Pathol; 1996 Jul; 6(3):217-23; discussion 23-4. PubMed ID: 8864278 [TBL] [Abstract][Full Text] [Related]
5. Molecular biology of glioblastoma: Classification and mutational locations. Soomro SH; Ting LR; Qing YY; Ren M J Pak Med Assoc; 2017 Sep; 67(9):1410-1414. PubMed ID: 28924284 [TBL] [Abstract][Full Text] [Related]
6. Anatomical localization of p53 mutated tumors: A radiographic study of human glioblastomas. Zhang T; Wang Y; Fan X; Ma J; Li S; Jiang T; Wang L J Neurol Sci; 2014 Nov; 346(1-2):94-8. PubMed ID: 25130928 [TBL] [Abstract][Full Text] [Related]
7. Necrogenesis and Fas/APO-1 (CD95) expression in primary (de novo) and secondary glioblastomas. Tohma Y; Gratas C; Van Meir EG; Desbaillets I; Tenan M; Tachibana O; Kleihues P; Ohgaki H J Neuropathol Exp Neurol; 1998 Mar; 57(3):239-45. PubMed ID: 9600216 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of GLS2 in glioblastoma cells is related to DNA hypermethylation but not to the p53 status. Szeliga M; Bogacińska-Karaś M; Kuźmicz K; Rola R; Albrecht J Mol Carcinog; 2016 Sep; 55(9):1309-16. PubMed ID: 26258493 [TBL] [Abstract][Full Text] [Related]
10. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression. Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308 [TBL] [Abstract][Full Text] [Related]
11. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. Lang FF; Miller DC; Koslow M; Newcomb EW J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151 [TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity at 11p15 and p53 alterations in malignant gliomas. Schiebe M; Ohneseit P; Hoffmann W; Meyermann R; Rodemann HP; Bamberg M J Cancer Res Clin Oncol; 2001 May; 127(5):325-8. PubMed ID: 11355148 [TBL] [Abstract][Full Text] [Related]
13. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052 [TBL] [Abstract][Full Text] [Related]
14. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932 [TBL] [Abstract][Full Text] [Related]
15. Correlation among pathology, genotype, and patient outcomes in glioblastoma. Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578 [TBL] [Abstract][Full Text] [Related]
16. Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme. Marutani M; Tonoki H; Tada M; Takahashi M; Kashiwazaki H; Hida Y; Hamada J; Asaka M; Moriuchi T Cancer Res; 1999 Oct; 59(19):4765-9. PubMed ID: 10519380 [TBL] [Abstract][Full Text] [Related]
17. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas. Sure U; Rüedi D; Tachibana O; Yonekawa Y; Ohgaki H; Kleihues P; Hegi ME J Neuropathol Exp Neurol; 1997 Jul; 56(7):782-9. PubMed ID: 9210874 [TBL] [Abstract][Full Text] [Related]
18. Glioblastoma multiforme in an Asian population: evidence for a distinct genetic pathway. Das A; Tan WL; Teo J; Smith DR J Neurooncol; 2002 Nov; 60(2):117-25. PubMed ID: 12635658 [TBL] [Abstract][Full Text] [Related]
19. Molecular genetic alterations in glioblastomas with oligodendroglial component. Kraus JA; Lamszus K; Glesmann N; Beck M; Wolter M; Sabel M; Krex D; Klockgether T; Reifenberger G; Schlegel U Acta Neuropathol; 2001 Apr; 101(4):311-20. PubMed ID: 11355302 [TBL] [Abstract][Full Text] [Related]
20. Genetic pathways to primary and secondary glioblastoma. Ohgaki H; Kleihues P Am J Pathol; 2007 May; 170(5):1445-53. PubMed ID: 17456751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]